Search
Sarepta Therapeutics Inc
SRPTAdd to Watchlist
17.480USD
-0.340-1.91%
Market hours 11/09, 10:42（ET）
1.85BMarket Cap
28.05P/E TTM
Today
-1.91%
5 Days
-6.12%
1 Month
-4.01%
6 Months
-12.40%
Year to Date
-18.77%
1 Year
-0.85%
Key Figures
17.910Open
18.770High
22.09KVolume
28.05P/E TTM
48.46P/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
17.820Prev. Close
17.020Low
381.81KTurnover
7.85P/E Static
1.21P/B
0.00%Div Yield TTM
1.96%ROA
24.68052wk High
0.07Volume Ratio
235.24MNet Profit
105.63MShares
0.6231EPS TTM
0.21Beta
4.91%ROE
14.68052wk Low
9.82%Amplitude
70.35%Gross Margin
1.85BMarket Cap
1.92Reward/Risk
4.45%Risk Rate
Recent
Transcripts
Sarepta Therapeutics Inc's Score
-0.10vs previous score
Forecast6.40
Financial Health7.27
Technical3.91
Valuation Dimensions8.62
Institutional Confidence10.00
Risk Assessment3.68
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Sarepta Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Sarepta Therapeutics Inc Latest Earnings Call Transcripts
Sarepta Therapeutics (SRPT) Q3 2026 Earnings Call: Guidance Raised as Elevidys Stabilizes
Sarepta’s Q3 2026 earnings call covered $324 million in product revenue, higher 2026 guidance, Elevidys stabilization and upcoming DM1 and FSHD data.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.27/0.06
Revenue / Forecast
381.35M/352.96M
Sarepta Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolSRPT
Number of employees1372
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 11.89% |
| AQR Capital Management, LLC | 7.38% |
| Vanguard Portfolio Management, LLC | 6.29% |
| State Street Investment Management (US) | 6.25% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 41.23% |
| Investment Advisor/Hedge Fund | 28.79% |
| Hedge Fund | 11.54% |
| Research Firm | 6.41% |
Related Instruments
+3.39%
+0.79%
-0.14%
+0.41%
-0.09%
+1.22%
-0.08%
+1.17%
+1.24%
-1.00%
-0.14%
-0.14%
-0.10%
+1.75%
+6.62%
+1.04%
+0.82%
-0.28%
+1.10%
+3.20%Popular Instruments
52145.700
+855.100 (+1.67%)
27758.700
+794.200 (+2.94%)
7524.100
+144.100 (+1.95%)
12797.000
-1.000 (-0.01%)
60395.000
+2253.000 (+3.88%)
6288.200
+147.600 (+2.40%)
87.642
-2.215 (-2.46%)
351.260
+8.890 (+2.60%)
178.650
-7.990 (-4.28%)
4118.990
+53.320 (+1.31%)
FAQs
What is the current price of Sarepta Therapeutics Inc (SRPT)?
The current price of Sarepta Therapeutics Inc (SRPT) is 17.82.
What is the symbol of Sarepta Therapeutics Inc?
The ticker symbol of Sarepta Therapeutics Inc is SRPT.
What is the 52-week high of Sarepta Therapeutics Inc?
The 52-week high of Sarepta Therapeutics Inc is 24.68.
What is the 52-week low of Sarepta Therapeutics Inc?
The 52-week low of Sarepta Therapeutics Inc is 14.68.
What is the market capitalization of Sarepta Therapeutics Inc?
The market capitalization of Sarepta Therapeutics Inc is 1.88B.
Is Sarepta Therapeutics Inc (SRPT) currently rated as Buy, Hold, or Sell?
According to analysts, Sarepta Therapeutics Inc (SRPT) has an overall rating of signal_hold, with a price target of 22.05.
What is the Earnings Per Share (EPS TTM) of Sarepta Therapeutics Inc (SRPT)?
The Earnings Per Share (EPS TTM) of Sarepta Therapeutics Inc (SRPT) is 0.62.